Correlation of FRMD6 and CLDN9 expression with clinicopathological features and prognosis in pancreatic cancer patients
10.3969/j.issn.1673-4130.2025.16.011
- VernacularTitle:胰腺癌患者组织FRMD6、CLDN9表达与临床病理特征及预后的相关性研究
- Author:
Huibin FENG
1
;
Jun SHAO
;
Chaofeng DONG
;
Baobao DANG
Author Information
1. 青海大学附属医院普通外科,青海西宁 810000
- Keywords:
pancreatic cancer;
FERM domain-containing protein 6;
claudin 9;
clinical significance;
prognosis
- From:
International Journal of Laboratory Medicine
2025;46(16):1978-1983
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of FERM domain-containing protein 6(FRMD6)and claudin 9(CLDN9)in pancreatic cancer(PC)and their correlation with clinicopathological features and prog-nosis.Methods A total of 95 patients with PC admitted to the hospital from September 2019 to September 2021 were selected as the research objects,and the cancer tissues and adjacent tissues that were resected dur-ing the operation of PC patients were collected.The expressions of FRMD6 and CLDN9 were detected by im-munohistochemistry.Kaplan-Meier survival curve and Log Rank x2 test were used to analyze the survival of PC patients.Multivariate Cox regression analysis was used to analyze the factors affecting the prognosis of PC patients.Results Compared with adjacent tissues,the positive expression rate of FRMD6 in PC tissues was significantly decreased(P＜0.05).The proportions of TNM stage Ⅲ and lymph node metastasis in patients with FRMD6 positive expression were significantly lower than those in patients with FRMD6 negative expres-sion(P＜0.05).Compared with the adjacent tissues,the positive expression rate of CLDN9 in PC tissues was significantly increased(P＜0.05).The proportion of TNM stage Ⅲ and lymph node metastasis in patients with positive expression of CLDN9 was significantly higher than that in patients with negative expression of CLDN9(P＜0.05).The 3-year overall survival rate of patients with FRMD6 positive expression(48.00％,12/25)was significantly higher than that of patients with FRMD6 negative expression(8.57％,6/70),and the difference was statistically significant(Log Rank x2=17.944,P＜0.001).The 3-year overall survival rate of patients with positive CLDN9 expression(7.35％,5/68)was significantly lower than that of patients with negative CLDN9 expression(48.15％,13/27),and the difference was statistically significant(Log Rank x2=25.159,P＜0.001).The positive expression of CLDN9,TNM stage Ⅲ,poor differentiation,and lymph node metastasis were all risk factors for the death of PC patients(P＜0.05),and the positive expression of FRMD6 was a protective factor(P＜0.05).Conclusion The expression of FRMD6 is low and CLDN9 is high in PC tissues.The expression of FRMD6 and CLDN9 is closely related to the clinicopathological characteristics of PC patients,and they are prognostic factors of PC patients.
